International Cannabis Weekly: 122
Highlights
Our Highlights
- Two cannabis-based medicines approved by the NHS.
- Thailand fast-tracking legal changes to improve access to medical cannabis.
- Cannabis Europa launches The Leaders Summit in New York.
- Prohibition Partners to host exclusive CBD event with Protein Agency in London.
Highlights
Europe
- Jersey to issue first high-THC cultivation licences early next year.
- Proposal to export cannabis flower blocked in North Macedonia.
- Estonia’s Social Affairs Committee has no plans to legalise recreational cannabis.
- In the UK, 1.4 million people use cannabis to help treat chronic health conditions.
- Melbourne-based Althea signs agreement with German distributor.
- Only 122 cannabis prescriptions have been issued in the UK.
- Cannabis self-cultivation laws under scrutiny in Malta.
- Slovenian NGO launches campaign to protect medical cannabis users.
- Prohibition Partners’ co-founder, Stephen Murphy, set to speak at Medcann World Forum.
Highlights
North America
- FDA approves human trials to study the efficacy of cannabis-based medicine.
- Alberta introduces new taxes for commercial cannabis cultivators.
- Massachusetts quarantines cannabis oil vaporisers.
- Georgia to begin issuing cannabis cultivation and retail licences.
- Florida’s medical cannabis programme reaches 400,000 patients.
- New Illinois bill to give cannabis businesses access to banking services.
- 14 dispensaries in Illinois receive ‘same-site’ licences to sell recreational cannabis.
- Cannabis New Brunswick moving towards privatisation after first-year losses.
Highlights
APAC
- China rejects cannabis but continues to invest in hemp.
- Advocates in India continue to push for cannabis legalisation.
- GPs in Western Australia receive green light to prescribe medicinal cannabis.
- Patient access to Australia’s medical cannabis programme grows 23% in October 2019.
Highlights
Latam & Caribbean
- Jamaica plans to overhaul cannabis regulations by March 2020.
- Medical cannabis companies appear in Peru, despite lack of regulation.
Highlights
Africa & Middle East
- Majority of licence holders in Zimbabwe remain unknown.
- Israel launches ministry report promoting its domestic cannabis industry.
- Together Pharma to cultivate five tonnes of medical cannabis in Israel.
Highlights
Health & Science
- Close to 40% of patients with rheumatic diseases use cannabis to treat their symptoms.
- One in eight women in Australia use cannabis to treat symptoms of endometriosis.
- Recent study shows that CBD promotes apoptosis in gastric cancer cells.
Highlights
The New Normal
On November 19th, Prohibition Partners is hosting an invite-only event in collaboration with Protein Agency, to launch The New Normal Report.
The report will document the rise of CBD goods and cannabis across a number of industries, including health & wellness, sport, food and drink.
The New Normal Report explores the changing behaviours across emerging industries, as well as the progressive brands and businesses that are embracing these shifts.
Highlights
The Global Cannabis Report
Prohibition Partners is proud to present The Global Cannabis Report, one of the most comprehensive studies ever completed on the international cannabis market.
The report predicts that the international cannabis market could be worth up to US$103.9 billion by 2024, and outlines key commercial opportunities for international operators and investors.
Highlights
IC3 Europe
IMN and Prohibition Partners are excited to announce the next event in our series of European cannabis investment conferences, IC3 Frankfurt, bringing investment and finance leaders to Europe’s largest cannabis market.
The IC3 conferences provide a meeting place for investors who wish to deploy capital or learn more about this exciting and high-growth new asset class, showcasing the cannabis companies and investment funds who are looking to raise money, and professional service providers who facilitate business across the industry.
Highlights
Sponsored content
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.